Skip to main content
Erschienen in: Supportive Care in Cancer 8/2017

24.02.2017 | Original Article

Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma

verfasst von: Hanne C. Lie, Anneli V. Mellblom, Mette Brekke, Arnstein Finset, Sophie D. Fosså, Cecilie E. Kiserud, Ellen Ruud, Jon H. Loge

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Given childhood cancer survivors’ risk of treatment-induced late effects, long-term follow-up care is recommended. We explored experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood malignant lymphoma in Norway.

Methods

We conducted five focus group interviews with 34 survivors (19 females; 21 Hodgkin/13 non-Hodgkin lymphoma survivors; mean age 39 years; mean time from diagnosis 26 years). Data was analyzed using principles of thematic analysis.

Results

Two main themes were identified: (1) the survivors’ experiences with late effects-related care and (2) their preferences for long-term follow-up care. Most of the survivors were dissatisfied with their late effects-related care due to perceptions of poor coordination of healthcare needs in a fragmented system, combined with a perceived lack of knowledge of late effects among themselves and general practitioners (GPs). All survivors valued long-term follow-up care. Oncologists were the preferred care providers, but GPs were considered acceptable providers if they had sufficient knowledge of late effects and routine examinations, short waiting times, and improved GP-oncologist collaboration.

Conclusions

Our results suggest that a shared care model of long-term follow-up care involving specialists, GPs, and the survivors themselves is likely to fulfill several of the currently unmet needs among adult survivors of childhood cancers. Improved patient education about late effects and follow-up care would aid self-management. The survivors’ concerns regarding lack of sufficient knowledge of late effects among GPs suggest a need for improving access to, and dissemination of, information of late effects.
Literatur
1.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E ( 2006) From cancer patient to cancer survivor: lost in transition. Washington, DC, Committee on Cancer Survivorship: Improving Care and Quality of Life. National Cancer Policy Board, Institute of Medicine, and National Research Council. National Academies Press. Hewitt M, Greenfield S, Stovall E ( 2006) From cancer patient to cancer survivor: lost in transition. Washington, DC, Committee on Cancer Survivorship: Improving Care and Quality of Life. National Cancer Policy Board, Institute of Medicine, and National Research Council. National Academies Press.
2.
Zurück zum Zitat Richards M, Corner J, Maher J (2011) The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors. Br J Cancer 105:S1–S4CrossRefPubMedPubMedCentral Richards M, Corner J, Maher J (2011) The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors. Br J Cancer 105:S1–S4CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Gatta G, Botta L, Rossi S et al (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47CrossRefPubMed Gatta G, Botta L, Rossi S et al (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47CrossRefPubMed
4.
Zurück zum Zitat Hudson MM, Ness KK, Gurney JG et al (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer. J Am Med Assoc 309:2371–2381CrossRef Hudson MM, Ness KK, Gurney JG et al (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer. J Am Med Assoc 309:2371–2381CrossRef
5.
Zurück zum Zitat Oeffinger KC, Mertens AC, Sklar et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355: 1572–1582. Oeffinger KC, Mertens AC, Sklar et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355: 1572–1582.
6.
Zurück zum Zitat Reulen RC, Winter DL, Frobisher C et al (2010) Long-term cause-specific mortality among survivors of childhood cancer. J Am Med Assoc 304:172–179CrossRef Reulen RC, Winter DL, Frobisher C et al (2010) Long-term cause-specific mortality among survivors of childhood cancer. J Am Med Assoc 304:172–179CrossRef
7.
Zurück zum Zitat Armstrong GT, Kawashima T, Leisenring W et al (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218–1227CrossRefPubMedPubMedCentral Armstrong GT, Kawashima T, Leisenring W et al (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218–1227CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Landier W, Bhatia S, Eshelman DA et al (2004) Development of risk-based guidelines for pediatric cancer survivors: the children’s oncology group long-term follow-up guidelines from the children’s oncology group late effects committee and nursing discipline. J Clin Oncol 22:4979–4990CrossRefPubMed Landier W, Bhatia S, Eshelman DA et al (2004) Development of risk-based guidelines for pediatric cancer survivors: the children’s oncology group long-term follow-up guidelines from the children’s oncology group late effects committee and nursing discipline. J Clin Oncol 22:4979–4990CrossRefPubMed
9.
Zurück zum Zitat Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24:5117–5124CrossRefPubMed Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24:5117–5124CrossRefPubMed
10.
Zurück zum Zitat Rowland JH, Kent EE, Forsythe LP (2013) Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer 119(Suppl 11):2094–2108CrossRefPubMedPubMedCentral Rowland JH, Kent EE, Forsythe LP (2013) Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer 119(Suppl 11):2094–2108CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Armenian SH, Hudson MM, Mulder RL et al (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the international late effects of childhood cancer guideline harmonization group. The Lancet Oncol 16:e123–e136CrossRefPubMed Armenian SH, Hudson MM, Mulder RL et al (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the international late effects of childhood cancer guideline harmonization group. The Lancet Oncol 16:e123–e136CrossRefPubMed
12.
Zurück zum Zitat Mulder RL, Kremer LC, Hudson MM et al (2013) Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncol 14:e621–e629CrossRefPubMed Mulder RL, Kremer LC, Hudson MM et al (2013) Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncol 14:e621–e629CrossRefPubMed
13.
Zurück zum Zitat Van Dorp W, Mulder RL, Kremer LC et al (2016) Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium. J Clin Oncol 34:3440–3450CrossRefPubMed Van Dorp W, Mulder RL, Kremer LC et al (2016) Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium. J Clin Oncol 34:3440–3450CrossRefPubMed
14.
Zurück zum Zitat Essig S, Skinner R, Nicolas X et al (2012) Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS One 7:e53201CrossRefPubMedPubMedCentral Essig S, Skinner R, Nicolas X et al (2012) Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS One 7:e53201CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Emery J (2014) Cancer survivorship—the role of the GP. Aust Fam Physician 43:521–525PubMed Emery J (2014) Cancer survivorship—the role of the GP. Aust Fam Physician 43:521–525PubMed
16.
Zurück zum Zitat Blaauwbroek R, Barf HA, Groenier KH et al (2012) Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv 6:163–171CrossRefPubMed Blaauwbroek R, Barf HA, Groenier KH et al (2012) Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv 6:163–171CrossRefPubMed
17.
Zurück zum Zitat Heirs M, Suekarran S, Slack R et al (2012) A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer 60:351–356CrossRefPubMed Heirs M, Suekarran S, Slack R et al (2012) A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer 60:351–356CrossRefPubMed
19.
Zurück zum Zitat Singer S, Gianinazzi ME, Hohn A et al (2013) General practitioner involvement in follow-up of childhood cancer survivors: a systematic review. Pediatr Blood Cancer 60:1565–1573CrossRefPubMed Singer S, Gianinazzi ME, Hohn A et al (2013) General practitioner involvement in follow-up of childhood cancer survivors: a systematic review. Pediatr Blood Cancer 60:1565–1573CrossRefPubMed
20.
Zurück zum Zitat Michel G, Greenfield DM, Absolom K et al (2009) Follow-up care after childhood cancer: survivors’ expectations and preferences for care. Eur J Cancer 45:1616–1623CrossRefPubMed Michel G, Greenfield DM, Absolom K et al (2009) Follow-up care after childhood cancer: survivors’ expectations and preferences for care. Eur J Cancer 45:1616–1623CrossRefPubMed
21.
Zurück zum Zitat Earle EA, Davies H, Greenfield D et al (2005) Follow-up care for childhood cancer survivors: a focus group analysis. Eur J Cancer 41:2882–2886CrossRefPubMed Earle EA, Davies H, Greenfield D et al (2005) Follow-up care for childhood cancer survivors: a focus group analysis. Eur J Cancer 41:2882–2886CrossRefPubMed
22.
Zurück zum Zitat Gibson F, Aslett H, Levitt G et al (2005) Follow up after childhood cancer: a typology of young people's health care need. Clin Effect Nurs 9:133–146CrossRef Gibson F, Aslett H, Levitt G et al (2005) Follow up after childhood cancer: a typology of young people's health care need. Clin Effect Nurs 9:133–146CrossRef
23.
Zurück zum Zitat Hamre H, Zeller B, Kanellopoulos A et al (2012) High prevalence of chronic fatigue in adult long-term survivors of acute lymphoblastic leukemia and lymphoma during childhood and adolescence. J Adol Young Adult Oncol 2:2–9CrossRef Hamre H, Zeller B, Kanellopoulos A et al (2012) High prevalence of chronic fatigue in adult long-term survivors of acute lymphoblastic leukemia and lymphoma during childhood and adolescence. J Adol Young Adult Oncol 2:2–9CrossRef
24.
Zurück zum Zitat Lie HC, Loge JH, Fosså SD (2015) Providing information about late effects after childhood cancer: lymphoma survivors’ preferences for what, how and when. Pat Educ Counsel 98:604–611CrossRef Lie HC, Loge JH, Fosså SD (2015) Providing information about late effects after childhood cancer: lymphoma survivors’ preferences for what, how and when. Pat Educ Counsel 98:604–611CrossRef
25.
Zurück zum Zitat Krueger RA, Casey MA (2009) Focus groups: a practical guide for applied research, vol 4. Sage, Los Angeles Krueger RA, Casey MA (2009) Focus groups: a practical guide for applied research, vol 4. Sage, Los Angeles
26.
Zurück zum Zitat Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef
27.
Zurück zum Zitat Thomas E, Magilvy JK (2011) Qualitative rigor or research validity in qualitative research. J Spec Pediatr Nurs 16:151–155CrossRefPubMed Thomas E, Magilvy JK (2011) Qualitative rigor or research validity in qualitative research. J Spec Pediatr Nurs 16:151–155CrossRefPubMed
28.
Zurück zum Zitat Rebholz CE, von der Weid NX, Michel G et al (2011) Follow-up care amongst long-term childhood cancer survivors: a report from the Swiss childhood cancer survivor study. Eur J Cancer 47:221–229CrossRefPubMed Rebholz CE, von der Weid NX, Michel G et al (2011) Follow-up care amongst long-term childhood cancer survivors: a report from the Swiss childhood cancer survivor study. Eur J Cancer 47:221–229CrossRefPubMed
29.
Zurück zum Zitat Arvidson J, Söderhäll S, Eksborg S et al (2006) Medical follow-up visits in adults 5–25 years after treatment for childhood acute leukaemia, lymphoma or Wilms’ tumour. Acta Pædiatr 95:922–928 Arvidson J, Söderhäll S, Eksborg S et al (2006) Medical follow-up visits in adults 5–25 years after treatment for childhood acute leukaemia, lymphoma or Wilms’ tumour. Acta Pædiatr 95:922–928
30.
Zurück zum Zitat Zebrack B (2009) Information and service needs for young adult cancer survivors. Support Care Cancer 17:349–357 Zebrack B (2009) Information and service needs for young adult cancer survivors. Support Care Cancer 17:349–357
31.
Zurück zum Zitat Khan NF, Evans J, Rose PW (2011) A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer 105:S46–S51 Khan NF, Evans J, Rose PW (2011) A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer 105:S46–S51
32.
Zurück zum Zitat Landier W, Chen Y, Namdar G et al (2015) Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol 33:3887–3893 Landier W, Chen Y, Namdar G et al (2015) Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol 33:3887–3893
33.
Zurück zum Zitat Nathan P, Daugherty C, Wroblewski K et al (2013) Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 7:1–8 Nathan P, Daugherty C, Wroblewski K et al (2013) Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 7:1–8
34.
Zurück zum Zitat Rubin G, Berendsen A, Crawford SM et al (2015) The expanding role of primary care in cancer control. Lancet Oncol 16:1231–1272 Rubin G, Berendsen A, Crawford SM et al (2015) The expanding role of primary care in cancer control. Lancet Oncol 16:1231–1272
35.
Zurück zum Zitat Grunfeld E, Julian JA, Pond G et al (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29:4755–4762 Grunfeld E, Julian JA, Pond G et al (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29:4755–4762
36.
Zurück zum Zitat Brennan ME, Gormally JF, Butow P et al (2014) Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 111:1899–1908 Brennan ME, Gormally JF, Butow P et al (2014) Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 111:1899–1908
37.
Zurück zum Zitat Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs 24:208–217 Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs 24:208–217
38.
Zurück zum Zitat Warrington L, Absolom K, Velikova G (2015) Integrated care pathways for cancer survivors – a role for patient-reported outcome measures and health informatics. Acta Oncol 54:600–608 Warrington L, Absolom K, Velikova G (2015) Integrated care pathways for cancer survivors – a role for patient-reported outcome measures and health informatics. Acta Oncol 54:600–608
39.
Zurück zum Zitat Epstein RM, Street RL, Jr. (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, NIH Publication No. 07-6225, Bethesda Epstein RM, Street RL, Jr. (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, NIH Publication No. 07-6225, Bethesda
40.
Zurück zum Zitat Landier W, Armenian SH, Lee J (2012) Yield of screening for long-term complications using the children’s oncology group long-term follow-up guidelines. J Clin Oncol 30:4401–4408 Landier W, Armenian SH, Lee J (2012) Yield of screening for long-term complications using the children’s oncology group long-term follow-up guidelines. J Clin Oncol 30:4401–4408
41.
Zurück zum Zitat Michel G, Vetsch J (2015) Screening for psychological late effects in childhood, adolescent and young adult cancer survivors: a systematic review. Curr Opin Oncol 27:297–305 Michel G, Vetsch J (2015) Screening for psychological late effects in childhood, adolescent and young adult cancer survivors: a systematic review. Curr Opin Oncol 27:297–305
42.
Zurück zum Zitat Berg C, Stratton E, Esiashvili N et al (2015) Young adult cancer survivors’ experience with cancer treatment and follow-up care and perceptions of barriers to engaging in recommended care. J Cancer Educ 31:1–13 Berg C, Stratton E, Esiashvili N et al (2015) Young adult cancer survivors’ experience with cancer treatment and follow-up care and perceptions of barriers to engaging in recommended care. J Cancer Educ 31:1–13
43.
Zurück zum Zitat Oeffinger KC, WHB Wallace (2006) Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediat Blood Cancer 46:135–142 Oeffinger KC, WHB Wallace (2006) Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediat Blood Cancer 46:135–142
44.
Zurück zum Zitat Lehoux P, Poland B, Daudelin G (2006) Focus group research and “the patient’s view”. Soc Sci Med 63:2091–2104CrossRefPubMed Lehoux P, Poland B, Daudelin G (2006) Focus group research and “the patient’s view”. Soc Sci Med 63:2091–2104CrossRefPubMed
45.
Zurück zum Zitat Kiserud CE, Loge JH, Fosså A et al (2010) Mortality is persistently increased in Hodgkin’s lymphoma survivors. Eur J Cancer 46:1632–1639CrossRefPubMed Kiserud CE, Loge JH, Fosså A et al (2010) Mortality is persistently increased in Hodgkin’s lymphoma survivors. Eur J Cancer 46:1632–1639CrossRefPubMed
Metadaten
Titel
Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma
verfasst von
Hanne C. Lie
Anneli V. Mellblom
Mette Brekke
Arnstein Finset
Sophie D. Fosså
Cecilie E. Kiserud
Ellen Ruud
Jon H. Loge
Publikationsdatum
24.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3651-6

Weitere Artikel der Ausgabe 8/2017

Supportive Care in Cancer 8/2017 Zur Ausgabe

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Brustkrebs-Prävention wird neu gedacht

04.06.2024 ASCO 2024 Kongressbericht

Zurzeit untersuchen Forschende verschiedene neue Ansätze zur Prävention von Brustkrebs bei Personen mit hohem Risiko. Darunter Denosumab, die prophylaktische Bestrahlung der Brust – und Impfungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.